What Analysts Are Saying About Alignment Healthcare Stock
Portfolio Pulse from Benzinga Insights
Analysts have provided mixed ratings for Alignment Healthcare (NASDAQ:ALHC) over the past quarter, with a range of opinions from bullish to bearish. The average 12-month price target has increased to $10.0, reflecting a 26.58% rise from the previous average. Key analysts have raised their price targets, indicating a positive outlook despite the company's financial challenges such as low net margin, ROE, and ROA, and high debt-to-equity ratio.
August 14, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed ratings for Alignment Healthcare, with an average 12-month price target of $10.0, up 26.58% from the previous average. Key analysts have raised their price targets, indicating a positive outlook despite financial challenges.
The increase in the average price target and the positive actions from key analysts suggest a short-term positive impact on ALHC's stock price. However, the company's financial challenges may temper this optimism.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100